Document is current
Any future updates will be listed below
-
Authors
Li, Huihui https://orcid.org/0000-0003-0511-1693
Chen, Xueting
Wang, James Jiqi https://orcid.org/0000-0002-8878-668X
Shen, Juan
Abuduwufuer, Kudusi
Zhang, Zhao
Dong, Zhensheng
Wen, Zheng
He, Jingwei
Chen, Silian
Li, Wanshun
Chen, Chen
Li, Fan
Fang, Xiaodong
Wang, Dao Wen https://orcid.org/0000-0002-9774-3980
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82330010, 82241034)
- License Information
-
More Information
Article History
Received: 16 July 2024
Revised: 3 January 2025
Accepted: 15 January 2025
First Online: 10 February 2025
Competing interests
: Daowen Wang is the editorial board member of Signal Transduction and Targeted Therapy, but he has not been involved in the process of manuscript handling. Other authors declare no conflict of interest.
: Animal experiments in this study were approved by the Institutional Animal Research Committee of Tongji Medical College (permit No. TJH-202311007) and the Ethics Committee of BGI (permit No. BGI-IRB A22019). All animal experiments were performed according to the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Studies involving human participants were reviewed and approved by the Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (permit No. TJ-IRB20221265). Written informed consent was obtained from the legal representatives of the deceased individuals prior to sample collection. All procedures adhered to ethical standards and regulations for the use of human biological materials.
